MGC Pharmaceutical

MGC Pharma Reaches 1,400 Prescription Milestone

MGC Pharmaceuticalshas seen a 40% growth in prescription numbers since October 2019, with average prescriptionorders rising to 22 per business day. The "Seed to Medicine" bio-pharm...

MGC Pharmaceuticals Receives Regulatory Green Light for Cannabis Dementia Drug

The Australian Therapeutic Goods Administration (TGA) has granted key approvals to the ASX-listed biotech firm, MGC Pharmaceuticals (ASX: MXC), to begin Phase IIB clinical trials o...